Product
Efavirenz
Aliases
Atripla, EFV, Stocrin, Sustiva
11 clinical trials
10 indications
Indication
Adult HealthIndication
Healthy Control ParticipantsIndication
MalariaIndication
B-cell TumorsIndication
HIV InfectionsIndication
HIVIndication
ContraceptionIndication
Healthy ParticipantsIndication
HIV InfectionIndication
AIDSClinical trial
A Single Sequence, 2-Period, Open-label Crossover Study in Healthy Subjects to Determine the Effect of a Moderate CYP3A4 Inducer on the Pharmacokinetics of OmaveloxoloneStatus: Completed, Estimated PCD: 2023-08-30
Clinical trial
A Phase 1, 3-Part, Open-label, Drug-Drug Interaction Study to Evaluate the Effect of a Moderate CYP3A4 Inhibitor, and of Strong and Moderate CYP3A4 Inducers on the Pharmacokinetics of TAK-279 in Healthy SubjectsStatus: Completed, Estimated PCD: 2023-12-18
Clinical trial
A Phase I, Open-label, Fixed-sequence, Two-period, Crossover, Drug-drug Interaction Study to Investigate the Effect of Efavirenz on the Pharmacokinetics of Ganaplacide and Lumefantrine Combination in Healthy ParticipantsStatus: Completed, Estimated PCD: 2022-11-22
Clinical trial
Study of the Pharmacokinetic Effects of Efavirenz on the Pharmacokinetics of SHR1459 in Healthy SubjectsStatus: Completed, Estimated PCD: 2022-12-02
Clinical trial
A Randomized, Blinded, 12-week Comparison of Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in HIV-1 Infected Treatment-naive Participants. There is a 36 Week, Open-label, Extension Phase for Eligible Participants.Status: Completed, Estimated PCD: 2007-08-01
Clinical trial
Impact of a Dolutegravir-based Regimen on Early Mortality of Severely Immunocompromised AIDS PatientsStatus: Completed, Estimated PCD: 2021-07-31
Clinical trial
A Pharmacokinetic Evaluation of Increased Dose Levonorgestrel Implant and Efavirenz-Based Antiretroviral Therapy In HIV-Infected Ugandan WomenStatus: Completed, Estimated PCD: 2019-12-05
Clinical trial
A PHASE 1, OPEN-LABEL, FIXED-SEQUENCE, 2-PERIOD STUDY TO ESTIMATE THE EFFECT OF MULTIPLE DOSE ABROCITINIB ON THE PHARMACOKINETICS OF SINGLE DOSES OF CAFFEINE, EFAVIRENZ, AND OMEPRAZOLE IN HEALTHY PARTICIPANTSStatus: Completed, Estimated PCD: 2022-02-26
Clinical trial
Efavirenz Pharmacokinetics and Pharmacogenomics in Older HIV-infected PatientsStatus: Completed, Estimated PCD: 2014-05-01
Clinical trial
A Pharmacokinetic Evaluation of Levonorgestrel Implant and Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)-Based Antiretroviral Therapy in HIV-infected Ugandan WomenStatus: Completed, Estimated PCD: 2014-09-01
Clinical trial
A Phase 4 Study of the Effect on Immune Reconstitution of a Lopinavir/Ritonavir-Based Versus an Efavirenz-based HAART (Highly Active Antiretroviral Therapy) Regimen in Antiretroviral-Naïve Subjects With Advanced HIV DiseaseStatus: Terminated, Estimated PCD: 2010-12-01